Page last updated: 2024-09-04

ivabradine and Graft-Versus-Host Disease

ivabradine has been researched along with Graft-Versus-Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aizawa, K; Hayasaka, T; Himuro, M; Ichikawa, T; Ishizawa, K; Ito, S; Nakamura, N; Suzuki, H; Toubai, T; Wanezaki, M; Watanabe, M; Yamada, A; Yamamoto, M; Yanagiya, R1

Other Studies

1 other study(ies) available for ivabradine and Graft-Versus-Host Disease

ArticleYear
Ivabradine as an Adjuvant Agent for Severe Heart Failure Occurring in the Early Phase after Allogeneic Hematopoietic Cell Transplantation.
    Internal medicine (Tokyo, Japan), 2022, Sep-15, Volume: 61, Issue:18

    Topics: Cardiotoxicity; Graft vs Host Disease; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Ivabradine; Transplantation Conditioning; Transplantation, Homologous

2022